Double blind, placebo-controlled, randomized, crossover, pharmacodynamic study of 10 and 20 mg doses of zaleplon and zolpidem.

被引：0
|
作者：
Drover, DR
Lemmens, HJM
Naidu, S
Cevallos, WH
Troy, S
Martin, PT
Stanski, DR
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Wyeth Ayerst Res, Radnor, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 63卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII105
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [1] A randomized double-blind placebo-controlled 10-way crossover study to show that a new zolpidem modified-release formulation improves sleep maintenance compared to standard zolpidem.
    Hindmarch, I
    Legangeux, E
    Emegbo, S
    Nixon, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P26 - P26
  • [2] Randomized, Placebo-Controlled, Double Blind, Crossover Clinical Trial With Zolpidem In Patients With Impaired Level Of Consciousness
    O'Valle Rodriguez, Myrtha
    Moliner Munoz, Belen
    Navarro Perez, Ma Dolores
    Balmaseda Serrano, Raquel
    Colomer Font, Carolina
    Ferri Campos, Joan
    Noe Sebastian, Enrique
    BRAIN INJURY, 2012, 26 (4-5) : 519 - 520
  • [3] A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Vortioxetine 10 mg and 20 mg in Adults With Major Depressive Disorder
    Jacobsen, Paula L.
    Mahableshwarkar, Atul R.
    Serenko, Michael
    Chan, Serena
    Trivedi, Madhukar H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (05) : 575 - 582
  • [4] Tenoxicam 20 mg or 40 mg after thoracotomy: A prospective, randomized, double-blind, placebo-controlled study
    Merry, AF
    Sidebotham, DA
    Middleton, NG
    Calder, MV
    Webster, CS
    ANAESTHESIA AND INTENSIVE CARE, 2002, 30 (02) : 160 - 166
  • [5] A randomized, double-blind, placebo-controlled crossover study on oral ATP administration
    Coolen, Erik
    Arts, Ilja
    Bours, Martijn
    Huyghebaert, Nathalie
    Cohen, Stuart Martien
    Bast, Aalt
    Dagnelie, Pieter
    PURINERGIC SIGNALLING, 2008, 4 : S196 - S197
  • [6] Octreotide in hepatorenal syndrome: A randomized, double-blind, placebo-controlled, crossover study
    Pomier-Layrargues, G
    Paquin, SC
    Hassoun, Z
    Lafortune, M
    Tran, A
    HEPATOLOGY, 2003, 38 (01) : 238 - 243
  • [7] Randomized, double-blind, placebo-controlled crossover study of donepezil in Down syndrome
    Kishnani, PS
    Spiridigliozzi, GA
    Heller, JH
    Sullivan, JA
    Crissman, BG
    Hauser, E
    Grambow, SC
    Doraiswamy, PM
    Krishnan, RR
    NEUROLOGY, 2005, 64 (06) : A106 - A106
  • [8] Estradiol in premenstrual asthma: A double-blind, randomized, placebo-controlled, crossover study
    Ensom, MHH
    Chong, G
    Zhou, DY
    Beaudin, B
    Shalansky, S
    Bai, TR
    PHARMACOTHERAPY, 2003, 23 (05): : 561 - 571
  • [9] Apilot double-blind randomized placebo-controlled crossover pharmacodynamic study of the centrally active aminopeptidase A inhibitor, firibastat, in hypertension
    Azizi, Michel
    Courand, Pierre-Yves
    Denolle, Thierry
    Delsart, Pascal
    Zhygalina, Valentina
    Amar, Laurence
    Lantelme, Pierre
    Mounier-Vehier, Claire
    De Mota, Nadia
    Balavoine, Fabrice
    Llorens-Cortes, Catherine
    JOURNAL OF HYPERTENSION, 2019, 37 (08) : 1722 - 1728
  • [10] Subcutaneous octreotide in cluster headache: Randomized placebo-controlled double-blind crossover study
    Matharu, MS
    Levy, MJ
    Meeran, K
    Goadsby, PJ
    ANNALS OF NEUROLOGY, 2004, 56 (04) : 488 - 494
12345